Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions.… Read more
Guangdong VTR Bio-Tech Co Ltd - Asset Resilience Ratio
Guangdong VTR Bio-Tech Co Ltd (300381) has an Asset Resilience Ratio of 7.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Guangdong VTR Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Guangdong VTR Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥215.61 Million | 7.45% |
| Total Liquid Assets | CN¥215.61 Million | 7.45% |
Asset Resilience Insights
- Limited Liquidity: Guangdong VTR Bio-Tech Co Ltd maintains only 7.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangdong VTR Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangdong VTR Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx SE
OTCGREY:ARGNF |
Biotechnology | 25.67% |
|
Halozyme Therapeutics Inc
NASDAQ:HALO |
Biotechnology | 12.71% |
|
Exicure Inc
NASDAQ:XCUR |
Biotechnology | 0.00% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
Annual Asset Resilience Ratio for Guangdong VTR Bio-Tech Co Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Guangdong VTR Bio-Tech Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.26% | CN¥332.13 Million | CN¥2.95 Billion | -6.95pp |
| 2023-12-31 | 18.21% | CN¥563.70 Million | CN¥3.09 Billion | -3.50pp |
| 2022-12-31 | 21.72% | CN¥688.89 Million | CN¥3.17 Billion | +21.56pp |
| 2016-12-31 | 0.16% | CN¥5.00 Million | CN¥3.21 Billion | -12.30pp |
| 2014-12-31 | 12.46% | CN¥120.04 Million | CN¥963.36 Million | -- |